FDA Rejects Ecstasy Drug as Treatment for PTSD

BUMMER –

June 7, 2024 – The decision reportedly came as a “shock” to observers, as psychedelics advocacy groups have gained widespread traction by steadily engaging in a decades-long effort to push the supposed benefits of the drugs as a way to help those struggling with trauma to open up to therapists about their experiences.

The shocked reaction of those within the field of psychology did not come as a surprise to Dr. Jennifer Bauwens. In comments to TWS, the clinical psychologist, licensed therapist, and clinical researcher explained how the march toward the institutional acceptance of psychedelics has been blatantly clear for some time.

“I first starting hearing about the use of psychedelic drugs like MDMA for trauma treatment in 2020,” she recalled. “Coming from the psychology field, I was seeing some of the top researchers in the trauma field touting this treatment. My alarm bells were going off. As I’ve done some of my own research and written about it, there’s been such a concerted effort to socialize the idea of psychedelics as a good thing. I don’t have any way to confirm it, but it certainly seems like the fix has been in for a long time.”